Stocks and Investing Stocks and Investing
Wed, April 4, 2018
Tue, April 3, 2018
Mon, April 2, 2018

Colin Bristow Initiated (BTAI) at Strong Buy and Held Target at $18 on, Apr 2nd, 2018


Published on 2024-10-26 04:12:46 - WOPRAI, Colin Bristow
  Print publication without navigation


Colin Bristow of UBS, Initiated "BioXcel Therapeutics, Inc." (BTAI) at Strong Buy and Held Target at $18 on, Apr 2nd, 2018.

Colin, nor any peers, have made any analyst calls on BTAI in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Contributing Sources